-
1
-
-
34548144593
-
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults
-
Sarcoma Meta-analysis Collaboration (SMAC)
-
Sarcoma Meta-analysis Collaboration (SMAC). Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Cochrane Database Syst Rev. 2000;CD001419.
-
(2000)
Cochrane Database Syst Rev
-
-
-
2
-
-
73449129773
-
How to work with a subgroup analysis
-
Evidence-Based Surgery Working Group
-
Dijkman B, Kooistra B, Bhandari M; Evidence-Based Surgery Working Group. How to work with a subgroup analysis. Can J Surg. 2009;52:515-22.
-
(2009)
Can J Surg
, vol.52
, pp. 515-522
-
-
Dijkman, B.1
Kooistra, B.2
Bhandari, M.3
-
3
-
-
11844302840
-
Treating individuals 2: Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation
-
DOI 10.1016/S0140-6736(05)17709-5, PII S0140673605177095
-
Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365:176-86. (Pubitemid 40091809)
-
(2005)
Lancet
, vol.365
, Issue.9454
, pp. 176-186
-
-
Rothwell, P.M.1
-
4
-
-
67649977705
-
Outcome based subgroup analysis: A neglected concern
-
Hirji KF, Fagerland MW. Outcome based subgroup analysis: a neglected concern. Trials. 2009;10:33.
-
(2009)
Trials
, vol.10
, pp. 33
-
-
Hirji, K.F.1
Fagerland, M.W.2
-
5
-
-
0037108235
-
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems
-
Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med. 2002;21:2917-30.
-
(2002)
Stat Med
, vol.21
, pp. 2917-2930
-
-
Pocock, S.J.1
Assmann, S.E.2
Enos, L.E.3
Kasten, L.E.4
-
6
-
-
0034712491
-
Subgroup analysis and other (mis)uses of baseline data in clinical trials
-
Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet. 2000;355:1064-9. (Pubitemid 30162810)
-
(2000)
Lancet
, vol.355
, Issue.9209
, pp. 1064-1069
-
-
Assmann, S.F.1
Pocock, S.J.2
Enos, L.E.3
Kasten, L.E.4
-
7
-
-
77951082212
-
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
-
doi:10.1136/bmj.c117
-
Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ. 2010;340:c117. doi:10.1136/bmj.c117.
-
(2010)
BMJ
, vol.340
-
-
Sun, X.1
Briel, M.2
Walter, S.D.3
Guyatt, G.H.4
-
8
-
-
33746037645
-
Misuse of baseline comparison tests and subgroup analyses in surgical trials
-
DOI 10.1097/01.blo.0000218736.23506.fe, PII 0000308620060600000039
-
Bhandari M, Devereaux PJ, Li P, Mah D, Lim K, Schünemann HJ, Tornetta P 3rd. Misuse of baseline comparison tests and subgroup analyses in surgical trials. Clin Orthop Relat Res. 2006;447:247-51. (Pubitemid 44324921)
-
(2006)
Clinical Orthopaedics and Related Research
, Issue.447
, pp. 247-251
-
-
Bhandari, M.1
Devereaux, P.J.2
Li, P.3
Mah, D.4
Lim, K.5
Schunemann, H.J.6
Tornetta III, P.7
-
9
-
-
0026501239
-
A consumer's guide to subgroup analyses
-
Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84.
-
(1992)
Ann Intern Med
, vol.116
, pp. 78-84
-
-
Oxman, A.D.1
Guyatt, G.H.2
-
10
-
-
0034466679
-
Debate: Subgroup analyses in clinical trials - Fun to look at, but don't believe them!
-
DOI 10.1186/CVM-1-1-025, 025
-
Sleight P. Debate: Subgroup analyses in clinical trials: fun to look at - but don't believe them! Curr Control Trials Cardiovasc Med. 2000;1:25-27. (Pubitemid 32219871)
-
(2000)
Current Controlled Trials in Cardiovascular Medicine
, vol.1
, Issue.1
, pp. 25-27
-
-
Sleight, P.1
-
11
-
-
10744220809
-
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)
-
DOI 10.1023/B:CEPR.0000012438.04416.00
-
Wikstrand J, Wedel H, Ghali J, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Card Electrophysiol Rev. 2003;7:264-75. (Pubitemid 38256110)
-
(2003)
Cardiac Electrophysiology Review
, vol.7
, Issue.3
, pp. 264-275
-
-
Wikstrand, J.1
Wedel, H.2
Ghali, J.3
Deedwania, P.4
Fagerberg, B.5
Goldstein, S.6
Gottlieb, S.7
Hjalmarson, A.8
Kjekshus, J.9
Waagstein, F.10
-
12
-
-
0031006966
-
P-value adjustments for subgroup analyses
-
discussion 323-31
-
Bristol DR. p-value adjustments for subgroup analyses. J Biopharm Stat. 1997; 7:313-21; discussion 323-31.
-
(1997)
J Biopharm Stat
, vol.7
, pp. 313-321
-
-
Bristol, D.R.1
-
14
-
-
0037374008
-
Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses
-
Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472.
-
(2003)
BMJ
, vol.326
, pp. 472
-
-
Song, F.1
Altman, D.G.2
Glenny, A.M.3
Deeks, J.J.4
-
15
-
-
1842453957
-
Subgroup analyses in randomized trials: Risks of subgroup-specific analyses; power and sample size for the interaction test
-
DOI 10.1016/j.jclinepi.2003.08.009, PII S0895435603003329
-
Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229-36. (Pubitemid 38456874)
-
(2004)
Journal of Clinical Epidemiology
, vol.57
, Issue.3
, pp. 229-236
-
-
Brookes, S.T.1
Whitely, E.2
Egger, M.3
Smith, G.D.4
Mulheran, P.A.5
Peters, T.J.6
-
16
-
-
0043240363
-
Predictive variables detailing the recurrence rate of soft tissue sarcomas
-
DOI 10.1097/00001622-200307000-00007
-
Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003;15:319-26. (Pubitemid 36994037)
-
(2003)
Current Opinion in Oncology
, vol.15
, Issue.4
, pp. 319-326
-
-
Grobmyer, S.R.1
Brennan, M.F.2
-
17
-
-
0036467991
-
Postoperative nomogram for 12-year sarcoma-specific death
-
DOI 10.1200/JCO.20.3.791
-
Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-6. (Pubitemid 34111387)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.3
, pp. 791-796
-
-
Kattan, M.W.1
Leung, D.H.Y.2
Brennan, M.F.3
|